Legal entity
regulation is the sole category represented across all 1 tracked stories. Alcon is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 5 original sources each against 3.4 for the same window.
Last mentioned: Jun 17, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Alcon is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 5 original sources each against 3.4 for the same window. The 6 average consequence score is below the beat benchmark of 6.2 in the same window. We currently track 1 Legal story that mention JBS USA, all published on March 17, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 54 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering JBS USA. Shared-story counts are live from our verified record — not editorial picks.
Alcon has terminated its planned acquisition of LENSAR following opposition from the Federal Trade Commission, highlighting intensified antitrust enforcement in the medical technology sector. Simultaneously, labor unrest at JBS USA and mixed earnings from Getty Images underscore broader economic pressures as global markets trend downward.
JBS USA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
